Market Place
Sourcing Support
Broken String Bio Adds Reid And Crutchfield To Board
23 Sep 2024 //
BUSINESSWIRE
Pepper chemical piplartine can prevent hearing loss from powerful antibiotics
08 Aug 2024 //
FIERCE BIOTECH
Regeneron Completes Acquisition of Decibel Therapeutics
25 Sep 2023 //
GLOBENEWSWIRE
Decibel Therapeutics Reports Second Quarter 2023 Financial Results
11 Aug 2023 //
GLOBENEWSWIRE
Regeneron To Acquire Decibel Therapeutics
10 Aug 2023 //
PRESS RELEASE
Decibel Therapeutics to Participate in Upcoming Jefferies Healthcare Conference
02 Jun 2023 //
GLOBENEWSWIRE
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at ASCO
01 Jun 2023 //
GLOBENEWSWIRE
Decibel to Participate in Barclays Gene Editing and Gene Therapy Summit
17 May 2023 //
GLOBENEWSWIRE
Decibel Therapeutics Reports 1Q 2023 FYR Results and Corporate Update
15 May 2023 //
GLOBENEWSWIRE
Decibel Announces Approval of Application by AEMPS for Development of DB-OTO
12 May 2023 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the (ASGCT) 26th Annual Meeting
10 May 2023 //
GLOBENEWSWIRE
Decibel Receives European Orphan Drug Designation for DB-OTO
30 Mar 2023 //
GLOBENEWSWIRE
Decibel to Participate in the Upcoming Guggenheim Healthcare Talks
28 Mar 2023 //
GLOBENEWSWIRE
Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors
21 Mar 2023 //
GLOBENEWSWIRE
Decibel Reports Fourth Quarter and Full Year 2022 Financial Results
14 Mar 2023 //
GLOBENEWSWIRE
Decibel to Present at the Upcoming SVB Securities Global Biopharma Conference
16 Feb 2023 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the 46th Annual ARO MidWinter Meeting
09 Feb 2023 //
GLOBENEWSWIRE
MHRA authorises Decibel’s CTA for trial of DB-OTO in paediatric patients
25 Jan 2023 //
CLINICAL TRIALS ARENA
Decibel Announces Approval of Clinical Trial Application by the U.K. Medicines
24 Jan 2023 //
GLOBENEWSWIRE
Decibel Announces Submission of Trial Applications for Gene Therapy DB-OTO
02 Nov 2022 //
BIOSPACE
Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO
17 Oct 2022 //
GLOBENEWSWIRE
Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors
12 Oct 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Participate in the Jefferies Cell and Genetic Summit
22 Sep 2022 //
GLOBENEWSWIRE
Decibel Therapeutics Announces Submission of(IND) Application Candidate DB-OTO
20 Sep 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Participate in Upcoming Investor Conferences
31 Aug 2022 //
GLOBENEWSWIRE
Decibel Therapeutics Reports Q2 Financial Results and Corporate Update
10 Aug 2022 //
GLOBENEWSWIRE
Decibel Tx Reports Positive Data from Interim Analysis of PIb Trial of DB-020
28 Jun 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
03 Jun 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the H.C. Wainwright Conference
17 May 2022 //
GLOBENEWSWIRE
Decibel Therapeutics Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the ASGCT
02 May 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Participate in Upcoming Investor Conferences
22 Mar 2022 //
GLOBENEWSWIRE
Decibel Tx Reports Q4 and FY 2021 Financial Results
18 Mar 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Conference
10 Feb 2022 //
GLOBENEWSWIRE
Decibel Tx Reports on Continued Progress of Lead Gene Therapy, DB-OTO
09 Feb 2022 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference
04 Jan 2022 //
GLOBENEWSWIRE
Decibel Announces Extension of Research Term under Strategic Collaboration
22 Nov 2021 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the Barclays & Gene Therapy Summit
08 Nov 2021 //
GLOBENEWSWIRE
Decibel Therapeutics Receives ODD and RPD Designations for DB-OTO
09 Sep 2021 //
GLOBENEWSWIRE
Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer
18 Aug 2021 //
GLOBENEWSWIRE
Decibel Therapeutics Expands World-Class Scientific Advisory Board
24 May 2021 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the American Society of Gene and Cell
28 Apr 2021 //
GLOBENEWSWIRE
Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO
24 Feb 2021 //
GLOBENEWSWIRE
Decibel to Present at the 44th Annual (ARO) Conference
19 Feb 2021 //
GLOBENEWSWIRE
Decibel Therapeutics to Present at the 44th Annual Association for Research
19 Feb 2021 //
BIOSPACE
Hearing disorder biotech Decibel Therapeutics files for a $75 million IPO
23 Jan 2021 //
NASDAQ
Decibel raises $82M as Laurence Reid looks to steer gene therapy pivot
09 Nov 2020 //
ENDPTS
Decibel Therapeutics Announces Exclusive Licensing Agreements
02 Nov 2020 //
BUSINESSWIRE
Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss
02 Nov 2020 //
BUSINESSWIRE
